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Epilepsy is a complex clinical condition characterized by repeated spontaneous seizures.
Seizures have been linked to multiple drivers including DNA damage accumulation.
Investigation of epilepsy physiopathology in humans imposes ethical and practical
limitations, for this reason model systems are mostly preferred. Among animal models,
mouse mutants are particularly valuable since they allow conjoint behavioral, organismal,
and genetic analyses. Along with this, since aging has been associated with higher
frequency of seizures, prematurely aging mice, simulating human progeroid diseases,
offer a further useful modeling element as they recapitulate aging over a short time-
window. Here we report on a mouse mutant with progeroid traits that displays repeated
spontaneous seizures. Mutant mice were produced by reducing the expression of the
gene Ft1 (AKTIP in humans). In vitro, AKTIP/Ft1 depletion causes telomere aberrations,
DNA damage, and cell senescence. AKTIP/Ft1 interacts with lamins, which control
nuclear architecture and DNA function. Premature aging defects of Ft1 mutant mice
include skeletal alterations and lipodystrophy. The epileptic behavior of Ft1 mutant
animals was age and sex linked. Seizures were observed in 18 mutant mice (23.6%
of aged ≥ 21 weeks), at an average frequency of 2.33 events/mouse. Time distribution
of seizures indicated non-random enrichment of seizures over the follow-up period, with
75% of seizures happening in consecutive weeks. The analysis of epileptic brains did not
reveal overt brain morphological alterations or severe neurodegeneration, however, Ft1
reduction induced expression of the inflammatory markers IL-6 and TGF-β. Importantly,
Ft1mutant mice with concomitant genetic reduction of the guardian of the genome, p53,
showed no seizures or inflammatory marker activation, implicating the DNA damage
response into these phenotypes. This work adds insights into the connection among
DNA damage, brain function, and aging. In addition, it further underscores the importance
of model organisms for studying specific phenotypes, along with permitting the analysis
of genetic interactions at the organismal level.
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INTRODUCTION
Epilepsy comprises a family of disorders characterized by
enduring predisposition to generate spontaneous seizures
(Scharfman, 2007; Fisher et al., 2014). Seizures are underpinned
by multiple mechanisms and their clinical outcome varies
widely (Scharfman, 2007). Regardless of their outcome, seizures
arise from disruption of mechanisms that create a balance
between neuronal excitation and inhibition. Factors corrupting
this balance result from alterations at different levels of brain
function, from ion channels to receptors, and neuronal circuits
(Stafstrom and Carmant, 2015). Epilepsies are often associated
with morphological brain abnormalities (Bertram, 2013), but at
least one-third have non-structural etiologies (Guerrini et al.,
2014). In the last years, concomitantly with human population
demographic changes, high incidence of epileptic disorders has
been associated with aging, whose specific pathophysiology is
under investigation (Leppik and Birnbaum, 2010).
Understanding the mechanistic path to disease is complex
in humans due to ethical issues, unavailability of controls and
high costs of human research. As a result, studies mostly rely on
the use of models, including human 3D cultures and stem cell
based systems (Riminucci et al., 2006; Simão et al., 2015), or, for
organismal analyses, genetically engineered mice (Baraban, 2007;
Saggio et al., 2014; Remoli et al., 2015; La Torre et al., 2018). One
of the way in which epilepsy has been modeled in mice is via
the inactivation of genes implicated in ion channels (Yu et al.,
2006; Baraban, 2007; Glasscock et al., 2012), or of genes encoding
for neurotransmitter receptors (Fonck et al., 2005). In addition,
epileptic phenomena have been observed in mouse models of
Alzheimer disease (Vogt et al., 2011; Ziyatdinova et al., 2011).
However, no other genetic models of age related epilepsy have
been yet described. Prematurely aging mouse mutants, which
recapitulate aging traits over a short time-window (Blasco, 2005;
Stewart et al., 2007), offer a specific advantage to model diseases
caused or exacerbated by aging, including brain pathologies.
An emerging cause for brain disease and for the aging brain
is DNA damage (Langie et al., 2017). DNA integrity poses a
challenge for the nervous system as its development depends on
a complex series of dynamic and adaptive processes associated
to DNA damage (Mckinnon, 2013). Unrepaired DNA lesions
have detrimental effects on the developing of a functional
nervous system and neural progenitor cells rely on DNA repair
systems during the developmental program. After completion of
neurogenesis, DNA repair is still of paramount importance to
safeguard the genome (Madabhushi et al., 2014), especially to
protect the neurons against reactive oxygen species (Langie et al.,
2017). DNA damage is also direct cause for cell senescence and
for a related inflammatory response (Campisi, 2013; López-Otín
et al., 2013).
Mouse mutants of DNA damage functions have opened the
path to establish a link between DNA damage and the seizure
phenotype (Shen et al., 2010; Bianchi et al., 2017). For example,
the inactivation of XRCC1, a central factor in the DNA single
strand break repair pathway, leads to profound neuropathology
involving behavioral phenotypes consistent with epilepsy (Lee
et al., 2009). Data based on studies in Drosophila suggest that
nuclear architecture and lamins could play a role into epilepsy
(Frost, 2016). However, the hierarchy and range of events
connecting nuclear architecture, molecular DNA function to
epileptic behavior is still to be dissected, along with the elements
exacerbating this pathology in aging.
DNA damage affects genome near to randomly, but some
chromosomal regions, such as telomeres, are more prone to DNA
instability. In mammals, telomeric DNA is composed of double-
stranded short tandem repeats of TTAGGG sequence forming
higher-order DNA structures binding a specialized protein
complex, known as shelterin (de Lange, 2005). We identified a
telomere-associated protein named AKTIP in humans (and Ft1
in mouse), which interacts with the shelterin members TRF1 and
TRF2 (Burla et al., 2015). AKTIP/Ft1 reduction causes telomere
aberrations, DNA instability and cell senescence (Burla et al.,
2015). In vivo, the genetic reduction of Ft1 causes premature
aging defects including skeletal alterations and lipodystrophy (La
Torre et al., 2018). AKTIP/Ft1 interacts with lamins (Burla et al.,
2016a,b), pivotal elements for the control of nuclear architecture
and DNA function, including DNA repair, replication and
transcription (Dittmer and Misteli, 2011). Importantly, Ft1
mutant mice share similarities with lamin mutant animals, which
aremodels of choice for human progeroid syndromes, linking the
Ft1model to premature aging and progeroid diseases (Burla et al.,
2016a,b, 2018).
Here we report that Ft1mutant mice are subjected to repeated
seizures. We show that this trait is not linked to overt brain
morphological alterations, but is age and inflammation linked.
We also demonstrate that this phenotype is sensitive to the
expression of the guardian of the genome p53, pointing to a role
of DNA function in the seizure phenotype.
RESULTS
Seizures in Ft1 Mutant Mice
Mice with reduced levels of Ft1 were generated using the knock
out first (kof) strategy based on the insertion into the target
gene (referred as kof allele) of the βgeok cassette (Testa et al.,
2004), which traps and truncates Ft1 nascent transcript reducing
the expression of the targeted gene (La Torre et al., 2018).
Previous observations of Ft1kof /kof mice revealed that mutant
animals display significant reduction in body weight and lifespan,
compared to controls. Twenty-one percent of the animals show a
severe body size reduction and early post-natal death (we refer
to these mice as severely affected Ft1kof /kof mice, abbreviated
with SA Ft1kof /kof or SA mutant mice). The leftovers, non SA
Ft1kof /kof mice have a mild phenotype, with a median survival of
113 weeks, allowing adult phenotype observation (La Torre et al.,
2018).
To investigate mutant mouse behavior, we worked on
a cohort of animals aged ≥ 21 weeks non SA Ft1kof /kof .
We recorded spontaneous behavioral abnormalities in non
SA Ft1kof /kof mice including episodes of motor tremors
and convulsions, fast runs, jumps, and excessive salivation
(Figure 1 and Supplementary Movies 1–3). Dissection of
video recordings indicated that non SA Ft1kof /kof displayed
sudden movements followed by facial twitching, violent hind
Frontiers in Genetics | www.frontiersin.org 2 November 2018 | Volume 9 | Article 581
Burla et al. p53-Sensitive Epilepsy in Ft1 Mutant Mice
limbs shaking and falling, back arching, short jerks in muscles
of the hind limbs and forelimbs extension, Straub tail and
incontinence, followed by short jerks and fast breathing
(Figure 1A and Supplementary Movies 1–3). Eventually,
animals stood up and returned to normal activity; after few
minutes switched to post-ictal phase characterized by short
periods of complete immobility, interrupted by short intervals
of movement (Supplementary Movies 4–6). Recording showed
moving rhythmical up-down or left-right, stroking mouth with
forepaws, in a repetitive motion, and appearing to be chewing
and grooming (Figure 1A and Supplementary Movies 4–6).
Temporal evaluation of the data indicated that non SA Ft1kof /kof
mice display a behavioral repertoire corresponding in quality
and duration to epileptic phenotypes (Figure 1B), as described
for other mouse models (Chabrol et al., 2010; Robie et al., 2017).
Over a total of 260 animals (including Ft1+/+, Ft1+/kof ,
and Ft1kof /kof ), 18 Ft1kof /kof exhibited at least one seizure
manifestation (Figures 2A,B). No seizure episodes were
observed in heterozygote Ft1+/kof or wt mice (Figure 2A).
The frequency of seizures reached a maximum of one seizure
episode per week. Of 18 seizure positive mutants, 7 exhibited one
seizure-like manifestation during their follow-up period, while
the leftover displayed more than one seizure. On average, we
observed 2.33 ± 0.14 seizures during the entire follow-up period
in the seizure positive mutants (Figure 2B). Time distribution
of seizures for each mutant animal experiencing more than one
seizure indicated non-random enrichment of seizures over the
follow-up period, with 75% of seizures happening in consecutive
weeks (Figure 2C).
Seizures of Ft1 Mutant Mice Are Age and
Gender Linked
To analyze the distribution of seizures during aging, we
subdivided mouse lifespan in three major intervals: young (3
≤ weeks ≤ 20), juvenile (21 ≤ weeks ≤ 60), and adult (61 ≤
weeks ≤ 100). We monitored, for each age interval, the fraction
of mice exhibiting seizures for the first time (Figure 3A). None of
young non SA Ft1kof /kof mice (n= 189) displayed seizures, while
seizures were observed in juvenile and adult mice, in 16 out of 68
and 2 out of 8, respectively.
We previously reported that non SA Ft1kof /kof mice display
growth defects, which start within the juvenile interval and
become prominent through aging (La Torre et al., 2018). We
then asked whether the seizure phenotype was paralleled by
age-associated growth impairment. We considered the difference
between the average body weight of wt (n = 6) and sex-matched
seizure positivemutant mice (n= 8) (1body weight), and plotted
it against the number of seizures observed in each mutant animal
FIGURE 1 | Ft1kof/kof mice exhibit seizures. (A) Representative movie frames from non SA Ft1kof/kof mice recording during and post seizure. Starting from left of the
seizure panel group: loss of postural equilibrium, arching of the back, Straub tail (third picture, white arrow) and incontinence (third picture, black arrow), recovery of
the postural equilibrium. Frames from the movie also show motor automatisms in the post seizure panel group, as chewing (first picture) and grooming (second
picture). (B) Progression of behavior of two Ft1kof/kof mice, during and post seizure events, each represented by a horizontal bar. The length of each bar indicates the
duration of the relative motor type. In turquoise seizure analysis of mouse ID #13489, and in purple the same analysis of mouse ID #16247.
Frontiers in Genetics | www.frontiersin.org 3 November 2018 | Volume 9 | Article 581
Burla et al. p53-Sensitive Epilepsy in Ft1 Mutant Mice
FIGURE 2 | Seizure frequency in Ft1kof/kof mice. (A) Percentages of mice that exhibited seizure; no seizures were observed in wt (**p < 0.01 χ2 test) or in
heterozygous Ft1+/kof mice (***p < 0.001 χ2 test). (B) Total number of seizure experienced by wt and Ft1kof/kof mice, each dot represents one mouse. Line
indicates average seizure number considering all Ft1kof/kof ; dashed line indicates average seizure number (2.33 ± 0.14) considering Ft1kof/kof which experienced
seizures (*p < 0.05 Student’s t-test). (C) Temporal seizure distribution for each Ft1kof/kof mouse which experienced more than one seizure. Each dot represents a
seizure episode. n, total number of analyzed mice.
to generate a regression curve (Figure 3B). The two variables
were linked by positive correlation (r2 = 0.60; ∗∗p < 0.01 in
Pearson’s R test).
Non SA Ft1kof /kof male mice were previously shown to display
a stronger phenotype as compared to Ft1kof /kof females (La Torre
et al., 2018). We thus decided to explore gender differences in the
seizure trait. We analyzed a cohort of non SA Ft1kof /kof animals
aged ≥ 21 weeks including 37 males and 39 females. Seizure
positive mutants were 37.8% amongmales and 10.3% among non
SA Ft1kof /kof female mice (Figure 3C).
In order to verify whether aging would induce variations in
Ft1 expression we monitored two cohorts of Ft1+/+ mice by
QPCR. Results indicate that there are no significant variation
in Ft1 expression with aging (Supplementary Figure 1A). In
addition, the human counterpart of Ft1, AKTIP, is also expressed
in brain cells (Supplementary Figure 1B).
Altogether these results indicate that Ft1 reduction causes
seizures, and that this phenotype parallels overall organismal
alterations characteristic of non SA Ft1kof /kof mice including age
dependent growth impairment and sex-linked defects (La Torre
et al., 2018).
Structure of Ft1 Mutant Brain
To define whether Ft1 function impacted on brain structure we
firstly measured skull and cranial length of non SA Ft1kof /kof
mice by X-ray analysis (Figure 4). Mutant and age- and
sex-matched wt animals were monitored at 2, 4, 8, and 13
months. Length measures revealed a continuous increase during
postnatal development in mutant mice as in controls, with a mild
alteration induced by Ft1 reduction at the age of 8 weeks (∗p <
0.05 in Student’s t-test) (Figures 4A–D). We then investigated
brain morphology by histological analysis. We firstly evaluated
the hippocampus, as hippocampal defects are often cause of
epilepsy. Nissl-staining of coronal sections of Ft1kof /kof brains
did not highlight overt alterations of hippocampal organization
or gross lesions, such as cell loss, structural deformation or scars
(Figures 5A–B). By immunofluorescence, we further analyzed
hippocampus cytoarchitecture. Semi-quantitative analysis
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FIGURE 3 | Seizures in Ft1kof/kof mice are age, body weight and sex-linked. (A) Percentage of Ft1kof/kof mice exhibiting first seizure clustered in three age intervals
(young: 3≤ weeks ≤ 20; juvenile: 21 ≤ weeks ≤ 60; adult: 61 ≤ weeks ≤ 100). No seizures were observed in young animals (**p < 0.01 and ***p < 0.001 in χ2 test).
(B) Correlation between the severity of growth defect and seizure frequency (r2 = 0.60; **p < 0.01 in Pearson’s R test). Each dot represents data from an individual
animal: body weight differences (1body weight) were obtained subtracting average body weight of Ft1kof/kof to the average weight of age and sex-matched wt
group. (C) Gender related differences in seizure behavior (**p < 0.01 in χ2 test). n, total number of analyzed mice.
of Parvalbumin-positive GABAergic interneurons showed a
mild reduction in Ft1kof /kof mice as compared to controls
(Figure 5C and Supplementary Figure 2). Then we evaluated
the somatosensory cortex cytoarchitecture: by Nissl-staining
and MAP2 immunofluorescence, we did not detect evident
alterations, including cortical thinning and layering defects in
Ft1kof /kof brain compared to wt (Figures 6A–C). The density
of Parvalbumin-positive GABAergic interneurons in the cortex
was non-significantly affected by Ft1 reduction (Figure 6D and
Supplementary Figure 3). Moreover, we did not observe any
evident macroscopic alterations in the whole brain structure,
as for example shrinkage of specific cerebral regions, ventricle
enlargement, corpus callosum thinning (data not shown),
or in brain volume (wt 177.95 mm3, Ft1kof /kof 189.46 mm3;
Supplementary Figure 4). Overall, these analyses did not reveal
robust differences between non SA Ft1kof /kof and control
mice, thus in principle excluding the presence of severe brain
degenerative processes.
p53-Sensitive Inflammatory Response in
Ft1 Mutant Brain
To investigate on molecular drivers for the seizure phenotype
observed in Ft1kof /kof mice we reasoned on studies in aging
and progeroid models which link DNA damage to systemic
inflammation and neurodegeneration (Campisi, 2013; López-
Otín et al., 2013). Given the progeroid traits observed in non SA
Ft1kof /kof mice and the implication of Ft1 in telomeremetabolism
and DNA function we decided to monitor the level of two
canonical, interrelated, inflammatory cytokines: IL-6 and TGF-β.
To get a full picture also on the connection with DNA damage,
we explored this aspect in non SA Ft1kof /kof mice, expressing
normal levels of the guardian of the genome p53 and in mice
defective for p53 expression due to heterozygous p53 inactivation
(Ft1kof /kof ; p53+/ko). QPCR analysis showed significant higher
levels of both IL-6 and TGF-β in Ft1kof /kof brains as compared
to age matched control mice (Figures 7A,B; ∗∗p< 0.01). Indeed,
in Ft1kof /kof ; p53+/ko mutant mice IL-6 and TGF-β activation
was reversed. These results suggest that the activation of the
DNA damage response pivotal player, p53, is a crucial event
in the organismal response to Ft1 reduction (Figures 7A,B).
As expected, p53 reduction did not impact on Ft1 expression,
which remained significantly reduced in Ft1kof /kof ; p53+/ko as in
Ft1kof /kof animals (Figure 7C).
Given the activation of the inflammatory cytokines and its
rescue by p53 reduction, we decided to explore the link between
p53, as an element directly associated with DNA function,
to the seizure phenotype of Ft1kof /kof mice. To this purpose,
we analyzed three cohorts of ≥ 21 weeks mice including
Ft1+/+;p53+/ko, Ft1+/kof ;p53+/ko and Ft1kof /kof ;p53+/ko mice, as
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FIGURE 4 | Ft1 reduction does not affect skull development. (A) X-ray analysis of craniofacial skeleton of wt and Ft1kof/kof mice. (B) Schematic view of mouse skull
and description of landmarks used for the anterior-posterior craniofacial skeleton length analysis. (C,D) Skull and cranium length analysis of Ft1kof/kof animals and
age-matched wt controls. Curves are not overall significantly different in Student’s t-test (p = 0.225), the difference of the skull length between Ft1kof/kof and Ft1+/+
animals is significantly different at the age of 8 weeks (*p < 0.05 in Student’s t-test). n, total number of analyzed mice.
compared to genetically and age matched controls. None of the
mice with the p53+/ko mutation displayed seizures, suggesting on
one side that p53 reduction alone does not cause seizures, and,
on the other side, that it rescues the seizure phenotype of our Ft1
mutant mice (Figure 7D).
Altogether these results establish a link among Ft1, p53,
inflammatory parameters and seizure behavior.
DISCUSSION
Epilepsy is a complex disorder codified by the concept of
predisposition to generate spontaneous seizures. Studies to
interpret seizure etiology are complex in humans, indeed many
open questions remain about its causes and mechanisms. An
important tool to understand and interpret epileptic phenomena
comes from model systems. Mutant mice in particular have been
instrumental for the identification of genes and gene-determined
molecular processes generating brain dysfunction and epileptic
phenotypes (Fonck et al., 2005; Yu et al., 2006; Baraban, 2007;
Löscher, 2011; Glasscock et al., 2012). In this work we report on
the epileptic behavior of a mouse mutant obtained by genetically
reducing the expression of the telomeric gene Ft1 (AKTIP in
humans) and present data supportive of a link between DNA
damage and epileptic behavior.
As a consequence to its biological function, AKTIP/Ft1
mutant cells display DNA replication defects, DNA and telomere
damage, along with cell senescence (Burla et al., 2015, 2016a).
AKTIP/Ft1 is linked to nuclear architecture through the
biochemical interaction occurring with A- and B-type lamins,
the main components of the nucleoskeleton, which, in turn, is
a pivotal element for the control of DNA function (Dittmer
and Misteli, 2011; Burla et al., 2018). Mice with reduced Ft1
expression display a segmental phenotype including reduced
subcutaneous fat, growth and skeletal defects. These traits
partly recapitulate the premature aging phenotypes observed
in progeroid mice generated by mutations of lamins or DNA
maintenance genes (Blasco, 2005; Stewart et al., 2007; Burla et al.,
2018), and are exacerbated in adult individuals as compared to
juvenile. Given the connection of AKTIP/Ft1 with both lamins
and DNA function, Ft1 mutant mice represent an attractive
model for investigating how these connections may impact on
the organismal phenotype and on different tissues and organs.
We report here that Ft1 mutant mice exhibit spontaneous
seizures. Digital movies document the seizure manifestation
highlighting typical traits, as loss of postural equilibrium, limb
jerks, and convulsions, as in other epileptic mouse models (Yang
et al., 2007; Minkeviciene et al., 2009; Chabrol et al., 2010;
Glasscock et al., 2012; Simeone et al., 2018). Seizures were
observed after the 20th week of age suggesting age-dependent
degenerative changes. Seizures also correlated with growth
impairment, which, in Ft1kof /kof mice, is exacerbated with aging
(La Torre et al., 2018). The frequency of seizures was higher
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FIGURE 5 | Ft1 reduction does not overtly affect hippocampal organization.
(A) Nissl-stained coronal sections of Ft1+/+ and Ft1kof/kof mouse brains
(upper panels), and higher magnification of the anterior hippocampus (bottom
panels), at about Bregma −1.22mm. (B) Nissl-stained hippocampus of
Ft1+/+ and Ft1kof/kof mice, at about Bregma −2.18mm. (C) Confocal
images showing parvalbumin-positive interneurons (PARV, in red) at the
hippocampal level; cell nuclei are labeled by DAPI staining (in blue). Scale bars:
(A) 500µm (upper panel), (A) 200µm (bottom panel), (B) 400µm, (C) (merge)
160µm, (C) (DAPI/PARV) 200µm.
in male mice, in line with the overall impact of Ft1 reduction
observed in our model (La Torre et al., 2018).
Along with behavioral descriptions, the importance of mouse
models resides in the fact that they allow investigating upstream
events to behavioral phenotypes, which, in humans, is complex
to explore. We thus exploited these animals to analyze the
pathophysiological path to seizures in an attempt to contribute
to establish experimentally proven links between DNA function
and brain alterations.
The analysis of brain morphology and cytoarchitecture in non
SA epileptic Ft1kof /kof mice did not highlight overt defects nor
macroscopic neurodegeneration. These results were obtained by
analyzing restricted brain areas and cell subtypes, and we do not
exclude the possibility of other or more subtle brain alterations
escaping our analysis. However, given the data, we hypothesized
that molecular, rather than overt structural aberrations would
underpin the epileptic behavior. This interpretation would be in
line with the fact that many types of epilepsy have been associated
with molecular alterations, rather than with macroscopic brain
structure defects (Guerrini et al., 2014).
On the basis of this hypothesis, we investigated on putative
molecular culprits for the seizure phenotype. Telomeres and
cell senescence have been implicated in disease and aging.
In particular, the secretion of a panel of inflammatory
signals (Senescence Associated Secretory Phenotype, SASP)
is considered a pivotal element in the alteration of tissue
homeostasis contributing to pathological status (Campisi et al.,
2001; Campisi, 2013). Given the function of AKTIP/Ft1 in
telomere protection along with its importance in preventing
cell senescence and DNA damage (Burla et al., 2015; La
Torre et al., 2018), we hypothesized that in Ft1 mutant mice
accumulation of damage and consequent senescence would
provoke inflammatory cytokine production, which, in turn, could
be implicated into the epileptic phenotype.
We thus measured inflammatory factors in the brain along
with exploring the implication of DNA function in inflammation.
In the brain of Ft1 mutant mice we detected the activation
of IL-6 and TGF-β. Both these factors are related with
inflammation (Coppe et al., 2010). IL-6 activation is assigned
to the SASP group of factors linked to cell senescence and
has been defined as a senescence biomarker in mice (Coppe
et al., 2010; Hudgins et al., 2018). The cytokine TGF-β, in
association with IL-6, is a further inflammatory stimulus (Sanjabi
et al., 2009). Altogether these data suggested a connection
between seizures and inflammation in the brain of Ft1kof /kof
mice.
To further investigate on the causative cascade of pathologic
events occurring in mice from Ft1 mutation to seizures, we
generated Ft1 mutant mice with a heterozygous ko mutation
in p53. p53 is a pivotal element in the DNA damage response
and we have demonstrated that p53 is activated in AKTIP
reduced primary human cells, which contributes to blocking
cell proliferation and inducing senescence (Burla et al., 2015;
La Torre et al., 2018). Interestingly p53 loss was shown
to rescue aging traits in vivo, by releasing DNA damage-
induced checkpoints and cell senescence (Varela et al., 2005).
In addition, p53 regulated senescence has been defined as a
pivotal element in generating the SASP phenotype. Consistently,
reduction of p53 expression rescues SASP related aging traits
(Baar et al., 2017). In Ft1 mutant mice, p53 reduction
not only reversed back the expression of IL-6 and TGF-
β, but also rescued the seizure phenotype. These results,
taken together, induce to speculate that the path to seizures
generated by Ft1 reduction could start with DNA damage,
including telomere dysfunction, followed by p53 activation,
cell senescence, and SASP. The latter could eventually induce
brain seizures, through a mechanism that remains to be
elucidated.
This interpretation of the data is interesting for investigating
on seizure causative events in basal physiological conditions, but
also in aging. In fact, aging is characterized by the exacerbation
of the alteration of the biological pathways which we have taken
into consideration, including senescence, genomic instability and
telomere fragility (López-Otín et al., 2013). These factors act on
aging in a cell intrinsic way and through extrinsic mechanisms
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FIGURE 6 | Ft1 reduction does not affect somatosensory cortex cytoarchitecture. (A) Nissl-stained coronal sections, showing somatosensory cortex of Ft1+/+ and
Ft1kof/kof mice brains. (B) MAP2-positive neurons (green) located in the cortical supragranular layers I-II-III and (C) in the infragranular layer V; cell nuclei are labeled by
DAPI staining (in blue). (D) Confocal images showing parvalbumin-positive interneurons (PARV, in red) and DAPI-positive nuclei (in blue). Scale bars: (A) 100µm, (B,C)
55µm, (D) 160µm.
(Lopez-Otin et al., 2016), as secretion of SASP factors (Coppe
et al., 2010) and chronic inflammation, profoundly altering tissue
microenvironment (Fulop et al., 2017), which, we would suggest,
could impact also on brain function.
In conclusion, this work adds new insights into the connection
among DNA damage, brain function, and inflammation. In
addition, it further underscores the importance of model
organisms for studying molecular path to specific phenotypes,
along with permitting the study of genetic interactions at the
organismal level. These aspects are even more relevant in
aging and brain research studies for which work in humans is
inaccessible due to time, ethical and sample accessibility issues.
MATERIALS AND METHODS
Mice and Ethical Statements
Mice were maintained and bred in a 12 h light/12 h dark cycle,
in a pathogen free unit of the animal house at Biology and
Biotechnology Department, Sapienza University. Animals were
housed and treated in accordance with protocol 355/2017-PR
approved by the Italian Ministry of Health. Animals carrying the
knockout first mutations in the Ft1 gene (Ft1 kof ) were obtained
as previously described (La Torre et al., 2018). In order to obtain
Ft1 and p53 mutant animals Ft1+/kof were crossed with p53+/ko
animals [kindly provided by G. Piaggio and S. Soddu IFO, Italy;
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FIGURE 7 | p53 reduction reverses inflammation and seizures in Ft1kof/kof mice. (A–C) QPCR expression quantification of IL-6, TGF-β and Ft1 in Ft1kof/kof ; Ft1+/kof
Ft1kof/kof in a wt or p53+/ko background (*p < 0.05; **p < 0.01; ***p < 0.001 Student’s t-test). (D) Expected versus observed number of mice with seizures in
Ft1kof/kof ; Ft1+/kof Ft1kof/kof in a wt or p53+/ko background. Expected seizure number was calculated considering the seizure frequency in Ft1kof/kof age matched
cohort (see Figure 2A). To note that none of Ft1kof/kof mice with the p53+/ko mutation displayed seizures. n, total number of analyzed mice.
(Jacks et al., 1994)]; subsequently doubly heterozygous mice were
intercrossed to obtain the desired genotypes. Offspring were
weaned at 3 weeks and tail biopsies were used for genotyping.
When needed, mice were anesthetized by intramuscular Zoletil
20 (Virbac S.A., France), or euthanized by asphyxiation with
carbon dioxide or cervical dislocation.
Genotyping
Mice were genotyped as previously described (La Torre et al.,
2018). Briefly genomic DNA was extracted from tail biopsies
digested 50◦C with a proteinase K/SDS solution using the
blackPREP Rodent Tail DNA Kit (Analytik Jena, Jena, Germany)
following manufacturer’s instructions.
Mice were PCR genotyped using the following primers:
Ft1 E4 F: 5′-GTGAAGCAGAAGCTGCCAGGAGT−3′;
Ft1 E6 R: 5′-AGCTCACCCGAGGTGGGATCAA−3′;
p53-X6 F: 5′-AGCGTGGTGGTACCTTATGAGC−3′;
p53-Neo19 F: 5′-GCTATCAGGACATAGCGTTGGC−3′;
p53-X7 R: 5′-GGATGGTGGTATACTCAGAGCC−3′
Seizure Observation
Seizures were observed during routine mouse handling. Where
indicated seizure and post-seizure events were video recorded.
The movies were then analyzed for specific behavioral signs as
previously described (Chabrol et al., 2010).
X-ray and Cephalometric Measurements
X-ray images were taken using Faxitron MX-20 (Faxitron X-ray
Corp.) at 24 kV for 6 s; images captured with Medical Imaging
Film HM Plus (Ferrania). Skull length and cranial length were
measured by Image J software as previously described (Rueden
et al., 2017).
Histological Analysis
Eight month-old mice were euthanized and brains were removed
and postfixed in 4% PFA for 2 h at 4◦C. Samples were then
immersed in a solution containing 30% sucrose in phosphate
buffer 0.1M at 4◦C for cryoprotection, embedded in cryostat
medium (Killik; Bio-Optica, Milan, Italy), and cut on the
cryostat (HM 550; Microm) in serial transverse 50µm thick
sections. Some brain sections (one section every 600µm) were
Nissl-stained to evaluate the gross cerebral morphology: briefly
sections were mounted on 2% gelatin-coated Superfrost slides
and air-dried overnight; slides were hydrated in distilled water
for 1min before staining in 0.1% Cresyl violet acetate (Sigma
Aldrich, St. Louis, MO) for 10min, dehydrated in an ascending
series of ethanol, cleared in xylene and cover-slipped with
Eukitt (Bioptica, Milan, Italy). Sections were examined at a
Nikon Eclipse 80i microscope Equipped with a Nikon DS-Fi1
camera. Brain volume of wt and Ft1kof /kof mice was calculated
considering Bregma 2.10mm to Bregma −2.54mm segments
Frontiers in Genetics | www.frontiersin.org 9 November 2018 | Volume 9 | Article 581
Burla et al. p53-Sensitive Epilepsy in Ft1 Mutant Mice
in Nissl-stained serial sections reconstructed by Neurolucida
software (MicroBrightField, Williston, VT, USA) and the
volume (expressed in mm3) was obtained by NeuroExplorer
software (MicroBrightField). For immunofluorescence, brain
sections were permeabilized with in PBS 0.3% Triton X-100
at RT on a tilting plate for 20min; then, to block unspecific
binding of the antibody, sections were incubated for 30min
at RT with 0.3% Triton X-100 and 10% normal donkey
serum or normal goat serum (Sigma-Aldrich) in PBS (pH
7.4). Sections were then incubated at 4◦C overnight with the
following antibodies: 1:7,500 anti-Parvalbumin (rabbit; Swant);
1:200 anti-MAP2 (mouse; Chemicon). Then, sections were
incubated with appropriate fluorochrome-conjugated secondary
antibodies, for 1h at RT: 1:400 Alexa Fluor 647, goat
anti mouse (Jackson ImmunoResearch Laboratories); 1:200
cyanine 3-conjugated secondary antibody, donkey anti-rabbit
(Jackson ImmunoResearch Laboratories); 1:200 cyanine 2-
conjugated secondary antibody, donkey anti-mouse (Jackson
ImmunoResearch Laboratories). Finally sections were incubated
with 4,6 Diamino-2 phenyindole Dilactate (DAPI; Sigma
Aldrich) in PBS 1:50 for 3min. Samples were washed and
coverslips were mounted with the anti-fade mounting medium
Mowiol. For double staining and 3D reconstructions, slides
were examined with a Leica TCS SP5 confocal laser scanning
microscope.
Cell Culture
Human foreskin primary fibroblasts (HPFs), HeLa (ATCC CCL-
2) and 293T (ATCC CRL-11268) cells were cultured in DMEM
with 10% FBS. SH-SY5Y (ATCC CRL-2266) cells were cultured
in EMEM supplemented with 10% FBS.
RNA Extraction and QPCR Analysis
Cells were lysed using the TRIzol reagent (Invitrogen).
Brains were removed from euthanized mice and frozen in
liquid nitrogen. RNA was extracted using the TRIzol reagent
(Invitrogen) according to manufacturer. After DNaseI treatment
(Invitrogen) RNA from cells and brains was reverse transcribed
into cDNA with oligo d(T) primer and OMNISCRIPT RT KIT
(Qiagen). QPCRs were performed as described (Piersanti et al.,
2015) using the following primers:
Ft1 E3 F: AACCAGTCCTCCACGAAGTGCA;
Ft1 E3 R: TAGGGCTTCGCTATGGGTAGAGCA;
Ft1 E6 F: CCGTCTTTCACCCACTAGTTGAT;
Ft1 E6 R: TTGCGAACGCTCTTTTCACA;
mGAPDH F: GTGGCAAAGTGGAGATTGTTGCC;
mGAPDH R: TGTGCCGTTGAATTTGCCGT;
IL-6 F: CTCTGGGAAATCGTGGAAAT;
IL-6 R: CCAGTTTGGTAGCATCCATC
TGF-β F: CCCTATATTTGGAGCCTGGA;
TGF-β R: CTTGCGACCCACGTAGTAGA;
AKTIP F: TCCACGCTTGGTGTTCGAT;
AKTIP R: TCACCTGAGGTGGGATCAACT
GAPDH F: TGGGCTACACTGAGCACCAG
GAPDH R: GGGTGTCGCTGTTGAAGTCA
Statistics
χ2 test was applied for comparisons of the mouse cohorts.
Independent data sets were analyzed with the Student’s t-test
(unpaired, two-tailed). Correlation analyses were performed via
Pearson’s R test.
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